98 related articles for article (PubMed ID: 15386562)
1. High sensitivity of chemiluminescent methodology for detection of clonal CDR3 sequences in patients with acute lymphoblastic leukemia.
Leal E; Jaloma-Cruz AR; Barros-Núñez P
Hematol Oncol; 2004 Jun; 22(2):55-61. PubMed ID: 15386562
[TBL] [Abstract][Full Text] [Related]
2. Detection and monitoring of clonality in peripheral blood and bone marrow of patients with B-cell lymphoproliferative disorders.
Leal E; Esparza-Flores MA; López-Guido B; Aguilar-Luna C; Aguilar-López L; Jaloma-Cruz AR; Medina C; Barros-Núñez P
Hematol Oncol; 2003 Mar; 21(1):25-31. PubMed ID: 12605420
[TBL] [Abstract][Full Text] [Related]
3. Study of minimal residual disease in B-cell lineage acute lymphoblastic leukemia of childhood, using clone-specific probes.
Botsonis T; Tsangaris GT; Mikraki V; Tzortzatou-Stathopoulou F
Anticancer Res; 1999; 19(3B):2211-20. PubMed ID: 10472333
[TBL] [Abstract][Full Text] [Related]
4. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
Nakao M; Janssen JW; Flohr T; Bartram CR
Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
[TBL] [Abstract][Full Text] [Related]
5. Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual disease.
Steward CG; Potter MN; Oakhill A
Leukemia; 1992 Nov; 6(11):1213-9. PubMed ID: 1434806
[TBL] [Abstract][Full Text] [Related]
6. Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
Miglino M; Grasso R; Pietrasanta D; Palmisano GL; Berisso G; Clavio M; Pierri I; Santini G; Canepa L; Gobbi M
J Exp Clin Cancer Res; 2001 Mar; 20(1):95-101. PubMed ID: 11370837
[TBL] [Abstract][Full Text] [Related]
7. Detection of immunoglobulin gene rearrangement in B-cell malignancies.
Ainoon O; Hamidah AB; Cheong SK; Hamidah HN
Malays J Pathol; 2000 Jun; 22(1):5-11. PubMed ID: 16329531
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M
Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates.
Engels K; Oeschger S; Hansmann ML; Hillebrand M; Kriener S
Hum Pathol; 2007 Sep; 38(9):1402-11. PubMed ID: 17560629
[TBL] [Abstract][Full Text] [Related]
11. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
Liu Y; Zhu P; Hu YM
Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction.
Yamazaki J; Baba K; Goto-Koshino Y; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):321-31. PubMed ID: 18977540
[TBL] [Abstract][Full Text] [Related]
13. [Clinical importance of semi-quantitative monitoring of lymphomas using the comparative polymerase chain reaction].
Slavícková A; Ivánek R; Cerný J; Sálková J; Trnĕný M
Cas Lek Cesk; 2002 Nov; 141(23):735-8. PubMed ID: 12650030
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction detection of rearranged immunoglobulin heavy chain DNA in plasma samples is useful in the diagnosis of B-cell lymphoma.
Tohda S; Murakami N; Nara N
Int J Hematol; 2000 Jul; 72(1):74-8. PubMed ID: 10979213
[TBL] [Abstract][Full Text] [Related]
15. [Development of a new strategy for minimal residual disease monitoring in children with B-precursor acute lymphoblastic leukemia].
Bonjean B; Grollet L; Visentin E; Sigaux F; Cayuela JM
Ann Biol Clin (Paris); 2004; 62(4):465-70. PubMed ID: 15297244
[TBL] [Abstract][Full Text] [Related]
16. Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR.
Kerst G; Kreyenberg H; Roth C; Well C; Dietz K; Coustan-Smith E; Campana D; Koscielniak E; Niemeyer C; Schlegel PG; Müller I; Niethammer D; Bader P
Br J Haematol; 2005 Mar; 128(6):774-82. PubMed ID: 15755280
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
19. Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.
Krampera M; Perbellini O; Vincenzi C; Zampieri F; Pasini A; Scupoli MT; Guarini A; De Propris MS; Coustan-Smith E; Campana D; Foà R; Pizzolo G
Haematologica; 2006 Aug; 91(8):1109-12. PubMed ID: 16885052
[TBL] [Abstract][Full Text] [Related]
20. Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias.
Li A; Goldwasser MA; Zhou J; Armstrong SA; Wang H; Dalton V; Fletcher JA; Sallan SE; Silverman LB; Gribben JG
Br J Haematol; 2005 Oct; 131(2):185-92. PubMed ID: 16197448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
